BofA raised the firm’s price target on Corpay (CPAY) to $379 from $377 and keeps a Buy rating on the shares. While Q1 revenue was a touch short of expectations, revenue guidance ex-Gringo and the midpoint of EPS was reiterated and the firm views guidance, sales momentum, and M&A transactions positively, the analyst tells investors. Corpay characterized the M&A pipeline as “very active,” notes the firm, which is “encouraged” by Corpay’s “repositioning toward a more corporate payments oriented company,” adds the analyst.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target lowered to $365 from $400 at UBS
- AvidXchange price target lowered to $10 from $12 at Baird
- Corpay price target lowered to $414 from $417 at Raymond James
- Corpay Inc: Positioned for Growth with Strategic Partnerships and Enhanced Revenue Channels
- Corpay, Inc. Reports Strong Q1 2025 Results
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue